2016
DOI: 10.1016/j.juro.2016.02.2302
|View full text |Cite
|
Sign up to set email alerts
|

Mp09-15 Improved Survival With Prostate Directed Treatment for Men With Advanced but Non-Metastatic Prostate Cancer– A Centers for Disease Control Breast and Prostate Cancer Quality and Patterns of Care (Cdc poc-Bp) Study

Abstract: The aim of this study was to develop and externally validate a novel model aimed at predicting cancer-specific mortality (CSM) after biochemical recurrence (BCR) among prostate cancer (PCa) patients treated with radical prostatectomy (RP) with or without adjuvant external beam radiotherapy (aRT) and/or hormonal therapy (aHT).METHODS: The development cohort included 689 consecutive PCa patients treated with RP between 1987 and 2011 at a single tertiary referral center. All men had a subsequent BCR, defined as 2… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles